Yixintang Pharmaceutical Group Co., Ltd. announced that it will raise a round of funding on June 1, 2023. The company will issue convertible corporate bonds in the transaction. The transaction has been approved by the shareholder of the company in 1st extraordinary general meeting of 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.89 CNY | -1.22% | +3.84% | -5.48% |
04-26 | Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-19 | Yixintang Pharmaceutical's Profit Falls 46% as Revenue Stays Nearly Flat | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.48% | 1.83B | |
-34.16% | 14.88B | |
-24.55% | 12.18B | |
+14.96% | 6.53B | |
-25.24% | 6.52B | |
-8.01% | 6.06B | |
-2.34% | 4.64B | |
+60.00% | 4.59B | |
-8.10% | 3.86B | |
-11.16% | 3.61B |
- Stock Market
- Equities
- 002727 Stock
- News Yixintang Pharmaceutical Group Co., Ltd.
- Yixintang Pharmaceutical Group Co., Ltd. announced a financing transaction